Ceftriaxone 1 g IV q24h x 7 days
If MRSA Risk Factors Present, ADD
Vancomycin
Ceftazidime 2 g IV q8h x 7 days
Alternative for patients with true beta-lactam allergy only. Refer to beta-lactam allergy assessment algorithm.
Moxifloxacin 400 mg PO* q24h
x 7 days
*If PO is not feasible, then IV is acceptable in these situations.
OR
Meropenem* 500 mg IV q6h
If *Pseudomonas risk is high
If confirmed Pseudomonas pneumonia, duration of therapy is 14 days.